Skip to main content
Erschienen in: European Journal of Orthopaedic Surgery & Traumatology 5/2016

19.05.2016 | Original Article • HIP - TRAUMA

The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery

verfasst von: Iftikhar Ahmed, M. A. Khan, V. Allgar, A. Mohsen

Erschienen in: European Journal of Orthopaedic Surgery & Traumatology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Antibiotic prophylaxis with cefuroxime can reduce the incidence of deep wound infection (DWI) in hip-fracture surgery, but may increase the risk of C. difficile infection (CDI). An alternative is gentamicin with beta-lactam for which a question exists around clinical effectiveness and safety, given the gentamicin-associated nephrotoxicity particularly in the elderly and narrower sensitivity spectrum. We compared 744 consecutive patients (group I—cefuroxime) with 756 in group II (gentamicin + flucloxacillin) who were well matched. There were 4 cases of CDI in the cefuroxime prophylaxis, whereas none in flucloxacillin plus gentamicin (group II). There was a statistically significant (p = 0.036) increased DWI rate in group II (2.5 %) as compared to group I (1.1 %). However, after controlling for age, gender, ASA grade, surgeon grade, implant type and type of anaesthesia, there was no statistically significant difference between the two groups (p = 0.146). 8.5 % of group I and 16.5 % of group II developed AKI post-operatively (p = 0.023); however, 79 % of group I and 80 % of in group II had complete resolution of AKI prior to their discharge. Further, a significant increase in inpatient deaths (p = 0.057) in group II was observed, but not at 30 days (p = 0.378).
Literatur
1.
Zurück zum Zitat Marsh D et al (2007) The care of patients with fragility fractures. British Orthopaedic Association, London Marsh D et al (2007) The care of patients with fragility fractures. British Orthopaedic Association, London
2.
Zurück zum Zitat White SM, Griffiths R (2011) Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 42(11):1230–1233CrossRefPubMed White SM, Griffiths R (2011) Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 42(11):1230–1233CrossRefPubMed
3.
Zurück zum Zitat Chesser T et al (2011) The management of hip fracture in adults. National Clinical Guideline Centre, London Chesser T et al (2011) The management of hip fracture in adults. National Clinical Guideline Centre, London
4.
Zurück zum Zitat Falls Free: Promoting a National Falls Prevention Action Plan: Research Review Papers (2005) NCOA Centre for Healthy Aging, pp 3–18 Falls Free: Promoting a National Falls Prevention Action Plan: Research Review Papers (2005) NCOA Centre for Healthy Aging, pp 3–18
7.
Zurück zum Zitat Peel ALG, Taylor EW (1991) Proposed definitions for the audit of postoperative infection: a discussion paper. Ann RCS 73:385–388 Peel ALG, Taylor EW (1991) Proposed definitions for the audit of postoperative infection: a discussion paper. Ann RCS 73:385–388
8.
Zurück zum Zitat Edwards C, Counsell A, Boulton C, Moran CG (2008) Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 90(6):770–777CrossRefPubMed Edwards C, Counsell A, Boulton C, Moran CG (2008) Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 90(6):770–777CrossRefPubMed
9.
Zurück zum Zitat Chiu K, Lau S, Fung B, Ng K, Chow S (1993) Plastic adhesive drapes and wound infection after hip fracture surgery. ANZ J Surg 63:798–801CrossRef Chiu K, Lau S, Fung B, Ng K, Chow S (1993) Plastic adhesive drapes and wound infection after hip fracture surgery. ANZ J Surg 63:798–801CrossRef
10.
Zurück zum Zitat Mackay DC, Harrison WJ, Bates JHJ, Dickendon D (2000) Audit of deep wound infection following hip fracture surgery. J R Coll Surg Edinb 45:56–59PubMed Mackay DC, Harrison WJ, Bates JHJ, Dickendon D (2000) Audit of deep wound infection following hip fracture surgery. J R Coll Surg Edinb 45:56–59PubMed
11.
Zurück zum Zitat SIGN Guidelines no. 111“Management of hip fracture in older people”—June 2009 SIGN Guidelines no. 111“Management of hip fracture in older people”—June 2009
12.
Zurück zum Zitat National Clostridium difficile Standards Group (2004) Report to the Department of Health. J Hosp Infect 56:S1–S38 National Clostridium difficile Standards Group (2004) Report to the Department of Health. J Hosp Infect 56:S1–S38
14.
Zurück zum Zitat Dubberke ER, Reske KA, Yan Y et al (2007) Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45(12):1543–1549CrossRefPubMed Dubberke ER, Reske KA, Yan Y et al (2007) Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45(12):1543–1549CrossRefPubMed
15.
16.
Zurück zum Zitat Wilcox MH, Freeman J, Fawley W et al (2004) Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother 2004(54):168–172CrossRef Wilcox MH, Freeman J, Fawley W et al (2004) Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother 2004(54):168–172CrossRef
17.
Zurück zum Zitat Kreisel D, Savel TG, Silver AL, Cunningham JD (1995) Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 1995(130):989–993CrossRef Kreisel D, Savel TG, Silver AL, Cunningham JD (1995) Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 1995(130):989–993CrossRef
18.
Zurück zum Zitat Gilbert DN (2010) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R (eds) Principle and practice of infectious diseases, 7th edn. Churchill Livingstone, New York, pp 307–336 Gilbert DN (2010) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R (eds) Principle and practice of infectious diseases, 7th edn. Churchill Livingstone, New York, pp 307–336
19.
Zurück zum Zitat Starks I, Ayub G, Walley G, Orendi J, Roberts P, Maffulli N (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70(1):21–26CrossRefPubMed Starks I, Ayub G, Walley G, Orendi J, Roberts P, Maffulli N (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70(1):21–26CrossRefPubMed
20.
Zurück zum Zitat Katzung BG (2001) Basic & clinical pharmacology. 9th Edition, lange medical books, vol 43. McGraw Hill, New York, pp 734–764 Katzung BG (2001) Basic & clinical pharmacology. 9th Edition, lange medical books, vol 43. McGraw Hill, New York, pp 734–764
21.
Zurück zum Zitat Mingeot-Leclerq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003–1012 Mingeot-Leclerq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003–1012
22.
Zurück zum Zitat Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL (1999) Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 43:1549–1555PubMedPubMedCentral Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL (1999) Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 43:1549–1555PubMedPubMedCentral
23.
Zurück zum Zitat Selby MN, Shaw S, Woodier N, Fluck RJ, Kolhe NV (2009) Gentamicin associated acute kidney injury. Q J Med 102:873–880CrossRef Selby MN, Shaw S, Woodier N, Fluck RJ, Kolhe NV (2009) Gentamicin associated acute kidney injury. Q J Med 102:873–880CrossRef
24.
Zurück zum Zitat Patterson DL, Robson JM, Wagener MM (1998) Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 13:735–739CrossRef Patterson DL, Robson JM, Wagener MM (1998) Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 13:735–739CrossRef
25.
Zurück zum Zitat Raveh D, Kopyt M, Hite Y, Rudensky B, Sonnenblick M, Yinnon AM (2002) Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Q J Med 95:291–297CrossRef Raveh D, Kopyt M, Hite Y, Rudensky B, Sonnenblick M, Yinnon AM (2002) Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Q J Med 95:291–297CrossRef
26.
Zurück zum Zitat Baciewicz AM, Sokos DR, Cowan RI (2003) Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharm 37:182–186 Baciewicz AM, Sokos DR, Cowan RI (2003) Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharm 37:182–186
27.
Zurück zum Zitat Levey AS et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100 Levey AS et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100
28.
Zurück zum Zitat Craig RG, Hunter JM (2008) Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaes 101:296–310CrossRef Craig RG, Hunter JM (2008) Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaes 101:296–310CrossRef
29.
Zurück zum Zitat Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMedPubMedCentral Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat AlBuhairan B, Hind D, Hutchinson A (2008) Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 90:915–919CrossRefPubMed AlBuhairan B, Hind D, Hutchinson A (2008) Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 90:915–919CrossRefPubMed
33.
Zurück zum Zitat Challagundla SR et al (2013) Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Nephrol Dial Transpl 28:612–619CrossRef Challagundla SR et al (2013) Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Nephrol Dial Transpl 28:612–619CrossRef
35.
Zurück zum Zitat Slobogean GP, Kennedy SA, Davidson D, O’Brien PJ (2008) Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma 22:264–269CrossRefPubMed Slobogean GP, Kennedy SA, Davidson D, O’Brien PJ (2008) Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma 22:264–269CrossRefPubMed
36.
Zurück zum Zitat Starks I et al (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70:21–26CrossRefPubMed Starks I et al (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70:21–26CrossRefPubMed
37.
Zurück zum Zitat Jenkins PJ, Teoh K, Simpson PM, Dave J, Simpson AH, Breusch S (2010) Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br 92:994–998CrossRefPubMed Jenkins PJ, Teoh K, Simpson PM, Dave J, Simpson AH, Breusch S (2010) Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br 92:994–998CrossRefPubMed
38.
Zurück zum Zitat Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R (1995) Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39:650–655CrossRefPubMedPubMedCentral Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R (1995) Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39:650–655CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Kumin GD (1980) Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study. JAMA 244:1808–1810CrossRefPubMed Kumin GD (1980) Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study. JAMA 244:1808–1810CrossRefPubMed
40.
Zurück zum Zitat Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P (1996) Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 40:2494–2499PubMedPubMedCentral Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P (1996) Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 40:2494–2499PubMedPubMedCentral
41.
Zurück zum Zitat Munckhof WJ, Grayson ML, Turnidge JD (1996) A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 37:645–663CrossRefPubMed Munckhof WJ, Grayson ML, Turnidge JD (1996) A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 37:645–663CrossRefPubMed
42.
Zurück zum Zitat Fujita K, Sayama T, Abe S, Murayama T, Tashiro H (1985) Age dependent aminoglycoside nephrotoxicity. J Urol 134:596–597PubMed Fujita K, Sayama T, Abe S, Murayama T, Tashiro H (1985) Age dependent aminoglycoside nephrotoxicity. J Urol 134:596–597PubMed
43.
Zurück zum Zitat Moore RD, Smith CR, Lipski JJ, Mellits ED, Leitman PS (1984) Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100:352–357CrossRefPubMed Moore RD, Smith CR, Lipski JJ, Mellits ED, Leitman PS (1984) Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100:352–357CrossRefPubMed
44.
Zurück zum Zitat Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of co-morbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331:1374CrossRefPubMedPubMedCentral Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of co-morbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331:1374CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat White SM, Rashid N, Chakladar A (2009) An analysis of renal dysfunction in 1511 patients with fractured neck of femur: the implications for peri-operative analgesia. Anaesthesia 64:1061–1065CrossRefPubMed White SM, Rashid N, Chakladar A (2009) An analysis of renal dysfunction in 1511 patients with fractured neck of femur: the implications for peri-operative analgesia. Anaesthesia 64:1061–1065CrossRefPubMed
Metadaten
Titel
The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery
verfasst von
Iftikhar Ahmed
M. A. Khan
V. Allgar
A. Mohsen
Publikationsdatum
19.05.2016
Verlag
Springer Paris
Erschienen in
European Journal of Orthopaedic Surgery & Traumatology / Ausgabe 5/2016
Print ISSN: 1633-8065
Elektronische ISSN: 1432-1068
DOI
https://doi.org/10.1007/s00590-016-1794-7

Weitere Artikel der Ausgabe 5/2016

European Journal of Orthopaedic Surgery & Traumatology 5/2016 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.